Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001081090 | SCV000556665 | benign | Tuberous sclerosis 2 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002256027 | SCV000850798 | likely benign | Hereditary cancer-predisposing syndrome | 2016-12-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000731964 | SCV000859838 | uncertain significance | not provided | 2018-03-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000731964 | SCV001988793 | benign | not provided | 2021-08-09 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001081090 | SCV002039638 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002256027 | SCV002531056 | benign | Hereditary cancer-predisposing syndrome | 2022-02-07 | criteria provided, single submitter | curation | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002281730 | SCV002571956 | likely benign | not specified | 2022-08-11 | criteria provided, single submitter | clinical testing | |
Tuberous sclerosis database |
RCV000042939 | SCV000066736 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation |